Dr. Mike S. Lee is a biotechnology entrepreneur and Founder and President of Milestone Development Services. He actively participates in the development of new technologies and their integration into industrial settings. He currently serves on the Leadership Board for the Department of Chemistry at the University of Florida.
Dr. Lee has more than 30 years of pharmaceutical industry experience. He has pioneered the application of LC/MS for research dealing with biomolecules, optimization of ADME, and physicochemical properties, natural products, drug metabolites, impurities, and degradants.
Prior to founding Milestone Development Services, Dr. Lee was with Bristol-Myers Squibb. He led interdisciplinary teams responsible for rapid analysis of discovery leads and preclinical drug candidates that contributed to the Food & Drug Administration approval of Buspar®, and Serzone®, and the accelerated development and approval of TAXOL®.
Dr. Lee is the author or co-author of over 50 scientific papers and patents. His recent patent on segmented flow technology is the basis of a company he founded, Mozaic Solutions, to address the primary targets for personalized medicine.
Dr. Lee is a founding member of the CPSA Charitable Foundation dedicated to focusing technology, resources, and expertise to advance human health. He received his BS degree in Chemistry at the University of Maryland and completed his MS and PhD.